6th MIM Pan-African Malaria Conference

[October 6-11, 2013]
Moving towards malaria elimination: Investing in research and control
The International Convention Centre, Durban, South Africa
The MIM conference is the largest gathering of the malaria community and therefore provides the ideal opportunity to showcase novel findings, innovations and ground breaking research. DNDi participated in two symposia.

8th European Congress on Tropical Medicine and International Health

[September 10 – September 13, 2013]
Copenhagen, Denmark
The congress endeavored to look with critical eyes on current achievements in international health with focus on the link between scientific knowledge and practice, as well as creating a forum for interaction with colleagues around the globe and develop ideas for future research.

International AIDS Society Conference 2013

[June 30 – July 3, 2013]
7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention
Kuala Lumpur, Malaysia
The world’s largest open scientific conference on HIV/AIDS was held Kuala Lumpur, Malaysia. DNDi co-hosted a session on closing the treatment gap for children living with HIV.

Sanofi and DNDi celebrate six years of collaboration in fighting malaria

[Paris, France, and Geneva, Switzerland– 25 April 2013]
Sanofi (EURONEXT, SAN and NYSE;SNY) and the Drugs for Neglected Diseases initiative (DNDi), an independent not-for-profit foundation, announce that on the occasion of World Malaria Day, more than 200 million treatments of ASAQ Winthrop have been distributed in Africa since the medication became available in 2007.
[PDF] [Français]

A Decade of R&D for Neglected Diseases in Africa

[June 4-5, 2013]
Endemic Country Research and Development for Patient Access
Nairobi, Kenya
On the occasion of DNDi’s 10th anniversary, DNDi and founding partner KEMRI brought together key African decision-makers and public health actors for this special event to explore the challenges and opportunities for research & development for neglected diseases in Africa – past and future!

World Leish 5

[May 13-17, 2013]
Porto de Galinhas, Pernambuco, Brazil
The Fifth World Leishmaniasis Congress was organized by the Oswaldo Cruz Foundation, the Brazilian Society of Tropical Medicine, the Brazilian Society of Protozoology, and the Brazilian Society of Parasitology.

New Oral Drug Candidate for African Sleeping Sickness

[Geneva, Switzerland and Kinshasa, Democratic Republic of the Congo – 6 December 2012]
Phase II/III Clinical Trial Launched in the Democratic Republic of the Congo and Central African Republic
A new oral‐only treatment for sleeping sickness has entered Phase II/III clinical study in patients with late‐stage sleeping sickness in the Democratic Republic of the Congo (DRC) and soon in Central African Republic (CAR). The study, initiated by the Drugs for Neglected Diseases initiative (DNDi) and its partners, will test the efficacy and safety of fexinidazole, with once daily tablets for ten days.
[Français] [Deutsch]

DNDi Applauds Call for Scale-Up of Pediatric HIV Treatment in US PEPFAR Blueprint for an AIDS-Free Generation

[New York, USA/Geneva, Switzerland – 30 November 30 2012]
Age-appropriate formulations of antiretroviral drugs urgently need to be developed and delivered to save the lives of babies and toddlers living with HIV/AIDS
The Drugs for Neglected Diseases initiative (DNDi) welcomed the US President’s Emergency Plan for AIDS Relief (PEPFAR)’s new ‘PEPFAR Blueprint: Creating an AIDS-Free Generation,’ released by US Secretary of State Hillary Clinton in advance of World AIDS Day, and its focus on ensuring ambitious scale-up of treatment and diagnosis for people with HIV/AIDS, including children living with HIV/AIDS.
Watch “Children living with HIV/AIDS: the reality of a neglected disease”, a short film on the daily life of a mother with an infected child in South Africa